EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY 4.0

Myopia control efficacy of second-generation defocus incorporated multiple segments spectacle lenses on fast progressing myopes: Study protocol of a randomised controlled trial

Ying Hon iD, Rachel Ka Man Chun iD, Tsz Wing Leung iD, Hua Qi iD, Keigo Hasegawa, Ka Yan Leung, Chi Ho To, Carly Siu Yin Lam, Dennis Yan-Yin Tse iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0335061 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2025. Verfasst von Ying Hon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China. Hauptthemen laut MEDLINE: Eyeglasses, Myopia. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hong Kong Polytechnic University, HOYA Thailand Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Spectacle-based interventions for myopia control are appealing to parents and children due to their non-invasive nature. However, long-term efficacy results remain modest and do not account for high-risk children with early-onset myopia and fast progression. This paper presents the protocol of a trial designed to evaluate the efficacy of the new-generation Defocus Incorporated Multiple Segments (DIMS) spectacle lenses in slowing the progression of myopia in children with early-onset and fast myopia progression. Methods and design This is a prospective, double-masked, active-controlled, randomised trial (ClinicalTrials.gov identifiers: NCT05888792 and NCT05888805). Participants are Chinese schoolchildren aged 4–12 years with myopia of at least −0.75 diopter (D) in both eyes and with fast progression (≥ 0.50 D per year) or fast axial growth (≥ 0.27 mm per year) in either or both eyes. They are age-stratified and randomly assigned to an experimental arm, a control arm or an auxiliary arm in a 1:1:1 ratio. The experimental arm receives new-generation DIMS spectacle lenses, while the control arm receives single-vision spectacle lenses. The control subjects will crossover to experimental lenses at the end of the first year, and all subjects will continue wearing experimental lenses in the second year. The auxiliary arm receives marketed DIMS spectacle lenses for two years. The primary and secondary outcome measures are the changes in cycloplegic objective refraction and axial length at 12 months from baseline. Peripheral refraction and choroidal thickness will also be monitored, and their relationships with myopia control efficacy will be explored.

Discussion

This study will provide insights into the efficacy of a new generation of DIMS technology for controlling myopia in children with early-onset and fast myopia progression, offering evidence-based practice for myopia management.

Trial registration

ClinicalTrials.gov identifiers: NCT05888792 and NCT05888805

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EyeglassesMyopiaChildChild, PreschoolFemaleHumansMaleDisease ProgressionDouble-Blind MethodProspective StudiesRefraction, OcularTreatment OutcomeRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
  • Research Centre for SHARP Vision, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
  • InnoHK, Centre for Eye and Vision Research, 17W Hong Kong Science Park, Shatin, Hong Kong, China.
  • Technical Research and Development Department, Vision Care Section, Hoya Corporation, Tokyo, Japan.

ORCID-Profile: Ying Hon, Rachel Ka Man Chun, Tsz Wing Leung, Hua Qi, Dennis Yan-Yin Tse

Förderung

  • Hong Kong Polytechnic University
  • HOYA Thailand Ltd.

Zitieren

APA

Hon, Y., Chun, R. K. M., Leung, T. W., Qi, H., Hasegawa, K., Leung, K. Y., To, C. H., Lam, C. S. Y., & Tse, D. Y. (2025). Myopia control efficacy of second-generation defocus incorporated multiple segments spectacle lenses on fast progressing myopes: Study protocol of a randomised controlled trial. PLOS One. https://doi.org/10.1371/journal.pone.0335061

Vancouver

Hon Y, Chun RKM, Leung TW, Qi H, Hasegawa K, Leung KY, et al. Myopia control efficacy of second-generation defocus incorporated multiple segments spectacle lenses on fast progressing myopes: Study protocol of a randomised controlled trial. PLOS One. 2025. doi:10.1371/journal.pone.0335061

BibTeX
@article{Hon2025,
  author = {Hon, Ying and Chun, Rachel Ka Man and Leung, Tsz Wing and Qi, Hua and Hasegawa, Keigo and Leung, Ka Yan and To, Chi Ho and Lam, Carly Siu Yin and Tse, Dennis Yan-Yin},
  title = {Myopia control efficacy of second-generation defocus incorporated multiple segments spectacle lenses on fast progressing myopes: Study protocol of a randomised controlled trial},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0335061}
}
Kostenlos starten →